| Novartis Pharma Schweiz AG - Nevanac 3 mg / ml, Augentropfensuspension | | 65711 | | 01 | | Nevanac 3 mg / ml | | Augentropfensuspension | | S01BC10 | | Nepafenac | | 05.08.2016 | | |
| | Composition | | nepafenacum 3 mg, benzalkonii chloridum 0.05 mg, carmellosum natricum, guari gummi, carbomerum 974P, acidum boricum, dinatrii edetas, propylenglycolum, natrii chloridum, natrii hydroxidum aut acidum hydrochloridum ad pH, aqua purificata q.s. ad suspensionem pro 1 ml. | | Packungsbestandteile | | Augentropfensuspension | | | | | | | | Active Agent | Dose |
|---|
| Nepafenacum | 3 mg/ml |
| | BAG: Active Agent | Dose |
|---|
| Nepafenacum | 3 mg |
| | | | Inactive agents | Dose |
|---|
| Boric Acid | | | Aqua Purificata | | | Benzalkonium Chloride | 0.05 mg/ml | | Carbomerum 974P | | | Carmellose Sodium | | | Dinatrii Edetas | | | Guari Gummi | | | Sodium Chloride | | | Natrii Hydroxidum aut Acidum Hydrochloridum ad Ph | | | Propylenglycol | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 3 ml | 12.73 | 30.25 | B | SL | Yes |
|
|
